Cempra (CEMP) Tops Q2 EPS by 16c; Updates Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Needham & Company Remains Bullish on Cempra (CEMP) Following Conference Call with Management
August 2, 2016 8:19 AM EDTNeedham & Company reiterated a Buy rating and $48.00 price target on Cempra, Inc. (NASDAQ: CEMP) following a conference call with management. Management is expecting an FDA Advisory Committee meeting for Solithera in October or November 2016 and guided for a U.S. launch in Jan 2017.... More
